Skip to main content
. 2019 Apr 3;44(10):2360–2371. doi: 10.1007/s11064-019-02789-2

Table 1.

Patient and sample characteristics

Experiment Sample ID Sex Age Ki-67 proliferation index Immunostaining positivity Histological diagnosis Tumor type
miRNA seq 1 M 48 5% TTF-1, Annexin, S100, EMA, CD63 Spindle cell oncocytoma Primary
miRNA seq 2 Normal
miRNA seq 3 F 68 5–8% TTF-1, Annexin, Gal-3, S100, EMA, CD63 Spindle cell oncocytoma Primary
miRNA seq 4 M 69 < 5% TTF-1, Annexin, Gal-3 Spindle cell oncocytoma Primary
miRNA seq 5 M 43 1.5% TTF-1, Annexin, Gal-3, S100, EMA Spindle cell oncocytoma Primary
miRNA seq 6 M 44 5% TTF-1, Annexin, Gal-3, S100, EMA Spindle cell oncocytoma Recurrent 1
miRNA seq 7 M 49 4–8% TTF-1, Annexin, Gal-3, S100, EMA Spindle cell oncocytoma Recurrent 2
miRNA seq 8 Normal
miRNA seq 9 M 52 4–8% TTF-1, Annexin, Gal-3, S100, EMA Spindle cell oncocytoma Recurrent 3
GSE51618
Transcriptome data GSM1249410 M NA 4% NA Non-invasive pituitary oncocytoma NA
Transcriptome data GSM1249411 M NA 1% NA Non-invasive pituitary oncocytoma NA
Transcriptome data GSM1249413 M NA 2% NA Non-invasive pituitary oncocytoma NA
Transcriptome data GSM1249421 M NA Normal
Transcriptome data GSM1249425 M NA Normal
Transcriptome data GSM1249423 F NA Normal